IL6 and infection: To further clarify the timing of this effect, we measured viable intracellular BCG in cells treated before and/or after infection with IL-6; we observed that either pre-, post- or pre- and postinfection IL-6 caused a significant increase in viable intracellular BCG at 24 and 48 h (Fig. 5b).